Navigation Links
PTC Therapeutics' President and CEO Elected AAAS Fellow
Date:1/19/2011

SOUTH PLAINFIELD, N.J., Jan. 19, 2011 /PRNewswire/ -- Stuart W. Peltz, Ph.D., President and CEO of PTC Therapeutics, Inc. (PTC), has been elected a Fellow of the American Association for the Advancement of Science (AAAS), the world's largest general scientific society and publisher of the journal Science.  AAAS Fellows are chosen by their peers and recognized for their scientifically or socially distinguished efforts to advance science or its applications.

(Logo: http://photos.prnewswire.com/prnh/20010919/PTCLOGO)

As part of the Biological Science Section, Dr. Peltz is recognized for his "distinguished contributions in the area of genetics and RNA biochemistry, specifically mRNA stability and decay."  Dr. Peltz co-founded PTC Therapeutics in 1998 with the goal of discovering, developing and commercializing innovative therapies in areas of high unmet medical need based on RNA biochemistry and post-transcriptional control mechanisms.  While a total of 503 Fellows were recognized for 2010, Dr. Peltz is one of only ten Fellows elected who are currently in industry.  

"On behalf of the Board and the broader PTC community, we all congratulate Stuart for the AAAS Council's recognition for the excellence and value of his work in genetics and RNA biochemistry.  We all agree this is well deserved," said Michael Schmertzler, Chairman of the Board of Directors of PTC Therapeutics.

The tradition of AAAS Fellows began in 1874.  Currently, members can be considered for the rank of Fellow if nominated by the steering groups of the Association's 24 sections, or by any three Fellows who are current AAAS members, or by the AAAS chief executive officer.  Each steering group then reviews the nominations of individuals within its respective section and forwards a final list to the AAAS Council.  The AAAS Council, the association's policymaking body, votes on the final list.

"This is a great honor, for which a very large portion of the credit goes to my students, collaborators, colleagues and employees at PTC," said Dr. Stuart Peltz, President and CEO.  "We are committed to applying innovative science to develop therapies for diseases that currently have little or no treatment options."  

About PTC Therapeutics, Inc.

PTC is a biopharmaceutical company focused on the discovery, development and commercialization of orally administered small-molecule drugs that target post-transcriptional control processes.  Post-transcriptional control processes regulate the rate and timing of protein production and are of central importance to proper cellular function.  PTC's internally discovered pipeline addresses multiple therapeutic areas, including rare genetic disorders, oncology and infectious diseases.  PTC has developed proprietary technologies that it applies in its drug discovery activities and is the basis for collaborations with leading biopharmaceutical companies.  For more information, visit the company's web site at www.ptcbio.com.


'/>"/>
SOURCE PTC Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Resolvyx Pharmaceuticals and Celtic Therapeutics Enter Final Agreement in Ophthalmology
2. ADVENTRX Announces Signing of Term Sheet for Acquisition of Poloxamer-Based Therapeutics
3. Echo Therapeutics to Present at the OneMedForum 2011 Conference
4. Esperion Therapeutics Initiates Phase 2 Clinical Study for ETC-1002
5. Altheus Therapeutics Completes Phase I Clinical Study of Zoenasa™ in Ulcerative Colitis
6. Echo Therapeutics Receives Funding and Commitment of Approximately $5.5 Million
7. Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc.
8. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 29th Annual J.P. Morgan Healthcare Conference in San Francisco, CA
9. Amicus Therapeutics to Present at the 29th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2011
10. Halozyme Therapeutics to Present at J.P. Morgan Healthcare Conference on January 12
11. Karyopharm Therapeutics Inc. Appoints Michael Kauffman, MD, PhD, as Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... America held the largest share in the ECG ... population and demand for remote monitoring ECG devices. On the ... is expected to witness the highest growth rate during the ... (U.S.), Becton, Dickinson and Company (U.S.), Medtronic plc ( ... ) and Mindray Medical International Limited ( China ...
(Date:12/2/2016)... India , December 2, 2016 ... report "In Vitro Diagnostics/IVD Market by Product (Instruments, ... Hematology), Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) ... global market is valued at USD 60.22 Billion ... at a CAGR of 5.5% during the forecast ...
(Date:12/2/2016)... 2, 2016 On Thursday, December ... excellence in research, development and innovation in the biopharmaceutical ... was held in the presence of Sergey Tsyb, Vice ... Russian Federation , Natalia Sanina, First Vice Chairman ... , Head of Roszdravnadzor, National Service of Control in ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... December 02, 2016 , ... Center for Autism and Related ... those affected by autism spectrum disorder (ASD) and other developmental disabilities. The group, which ... give parents and other caregivers the opportunity to share stories and advice, seek help, ...
(Date:12/2/2016)... NY (PRWEB) , ... December 02, 2016 , ... ... an inspirational interview of two ostomy patients, standing as living proof that attitude ... suffer from digestive diseases and issues that spike around the holidays. This campaign ...
(Date:12/2/2016)... ... December 02, 2016 , ... CloudLIMS.com, a class-leading provider of ... Lite. CloudLIMS Lite helps biobanks, clinical, research and testing laboratories keep track of ... new version is a faster and a more efficient product, allowing batch processing ...
(Date:12/2/2016)... ... 2016 , ... Rijuven Corp launches rejiva ( http://www.rejiva.com ), a unique wearable ... wearable health technology on the market can deliver all that rejiva can. , “Rejiva ... about their health than the usual heart rate and steps taken”, adds Evens Augustin, ...
(Date:12/2/2016)... ... 02, 2016 , ... On November 24th, 2016, Thanksgiving morning, ... different sites throughout Miami-Dade and Broward counties. This is the largest meal delivery ... Thanksgiving morning by putting together individual meals via assembly lines and passing them ...
Breaking Medicine News(10 mins):